Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  BULK DEALS
Bulk Deals      
Checkpoint Trends Ltd.
BSE Code 531099
ISIN Demat INE396H01019
Book Value 3.60
NSE Code NA
Dividend Yield % 0.00
Market Cap 574.99
P/E 39.49
EPS 2.66
Face Value 10  
 
 
   
Deal DateCompany NameClient NameTranQty.(000's)ValuePriceTrade(Rs.in Lakhs)Close Price
09-Dec-2025 Rubra Medicaments MALINI PRADEEP SAXENABUY 55000113.976268350105.15
09-Dec-2025 Rubra Medicaments MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDSELL 35377113.974031916.69105.15
23-Oct-2025 Rubra Medicaments PACE STOCK BROKING SERVICES PVT LTDSELL 3001958.851766618.15105.15
17-Oct-2025 Rubra Medicaments NEO APEX VENTURE LLPSELL 2773459.451648786.3105.15
26-Sep-2025 Rubra Medicaments MUKESH ASWALSELL 7827246.973676435.84105.15
22-Sep-2025 Rubra Medicaments MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDSELL 3258043.421414623.6105.15
22-Sep-2025 Rubra Medicaments PACE STOCK BROKING SERVICES PVT LTDSELL 7231443.423139873.88105.15
22-Sep-2025 Rubra Medicaments PRADEEP SAXENABUY 7000043.423039400105.15
19-Sep-2025 Rubra Medicaments PACE STOCK BROKING SERVICES PVT LTDBUY 7231446.13333675.4105.15
08-Sep-2025 Rubra Medicaments MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDBUY 3000038.621158600105.15
02-Sep-2025 Rubra Medicaments NEO APEX VENTURE LLPSELL 4000032.731309200105.15
01-Sep-2025 Rubra Medicaments GOLDEN BIO ENERGY LIMITEDSELL 5000028.231411500105.15
01-Sep-2025 Rubra Medicaments NEO APEX VENTURE LLPBUY 4000028.221128800105.15
01-Sep-2025 Rubra Medicaments RAJVANSH ELECTRICALS PRIVATE LIMITEDSELL 10000029.942994000105.15
08-Aug-2025 Rubra Medicaments ANKIT MEHRASELL 9235143.674032968.17105.15
08-Aug-2025 Rubra Medicaments MUKESH ASWALBUY 2740043.671196558105.15
08-Aug-2025 Rubra Medicaments PRADEEP SAXENABUY 3880043.671694396105.15
01-Aug-2025 Rubra Medicaments MUKESH ASWALBUY 2749741.181132326.46105.15
10-Jul-2025 Rubra Medicaments MUKESH ASWALBUY 2910031.26909666105.15
10-Jul-2025 Rubra Medicaments MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDSELL 4120031.221286264105.15
Page 1 of 7
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.